Related Experiment Video
Updated: Feb 9, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
[Malignant lymphoma: update on pathophysiology and management]
1National Hospital Organization Nagoya Medical Center.
Abstract:
Comprehensive research of the pathogenesis of malignant lymphoma has resulted in the introduction of some novel concepts of treatment strategy. The cell of origin (COO) of diffuse large B cell lymphoma (DLBCL) can be identified using gene expression profiling and then becomes the most critical indicator of DLBCL. The stratification by COO is essential when incorporating molecule-targeting agents into DLBCL treatment. The era of tumor immunity has arrived. Lately, immune checkpoint inhibitors, adoptive cell immunotherapy, and other immune therapies have been transforming the management of malignant lymphoma. Now bench and bed have been getting engaged in the field of lymphoma.
Related Concept Videos
Pneumonia II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension II: Pathophysiology
Pathophysiology of Vomiting
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Heart Failure II: Pathophysiology

